This bill, known as the FAIR Act, would allow the U.S. Food and Drug Administration to approve certain medicines and permit clinical trials for life-threatening diseases more quickly by recognizing approvals from trusted international regulatory authorities. It directly affects drug manufacturers, patients with serious illnesses, and U.S. healthcare providers by creating a new pathway where medicines already approved by agencies like the European Medicines Agency or Health Canada could receive reciprocal marketing approval in the United States. The legislation establishes a 30-day timeline for FDA review of these reciprocal requests and includes provisions for clinical trials authorized abroad, while maintaining safety oversight through withdrawal mechanisms if adverse events occur. The bill specifies that only products intended for immediately life-threatening conditions would qualify under this streamlined process.
The Southwestern Power Administration Fund Establishment Act creates a new fund within the U.S. Treasury to consolidate the Southwestern Power Administration's (SPA) existing receipts, unspent balances from prior appropriations, and future funding. This fund will directly support the SPA - a federal agency managing hydroelectric power marketing - by covering operational costs for power transmission systems, electricity marketing, infrastructure construction, and related administrative expenses. The bill transfers unspent balances from three specific past funds into this new account and updates budget laws to redirect future SPA funding to it. The fund remains available until spent, with excess amounts annually returned to the U.S. Treasury.
Enhanced Iran Sanctions Act of 2025 This bill imposes sanctions on certain foreign persons (individuals and entities) that are involved in Iran's petroleum sector as well as certain associated persons. The bill also requires or authorizes actions to facilitate the enforcement of sanctions on Iran. Specifically, the bill requires the President to impose visa- and property-blocking sanctions on any foreign person that, after the bill's enactment, knowingly engages in any transaction related to the processing, export, or sale of oil, condensates, gas, liquefied natural gas, or other petrochemical products in whole or in part from Iran. The President must also impose sanctions on certain foreign persons associated with a sanctioned individual or entity. For example, the President must sanction the subsidiaries and corporate officers of a sanctioned business. The bill provides certain exceptions to these sanctions, including specifying that sanctions do not apply to the importation of goods or to conducting or facilitating transactions for humanitarian assistance. The Department of State must establish an interagency working group that shall seek to establish a multilateral contact group to coordinate international efforts to enforce sanctions on Iran. The bill expands the State Department rewards program to authorize a reward payment to any individual who furnishes information leading to the identification of a person (1) subject to sanctions under this bill, or (2) that has attempted or is attempting to evade sanctions under this bill.
This bill authorizes $150 million annually for fiscal years 2026 through 2031 to fund fundamental plant biology research at the National Science Foundation. The funds will be distributed through competitive grants to universities, nonprofit groups, private companies, and government agencies for research on plant and microbial biology relevant to agriculture, food, and biotechnology. The legislation also updates the legal definition of a nonprofit organization within the NSF's governing statute to align with current tax code requirements.
This bill reauthorizes funding for Agricultural and Food Policy Research Centers, which conduct research on food systems and agricultural policy. It directly affects these research centers by extending their authorization period and increasing their annual funding from $10 million to $15 million. The key provision amends existing law to provide $15 million per year for fiscal years 2027 through 2031, replacing the previous funding levels that expired in 2023. This change ensures continued financial support for the centers' research activities over a five-year period.
This bill authorizes the Attorney General to provide grants to law enforcement agencies and nonprofit organizations that partner to create or support blue envelope programs. These programs are designed to help individuals with autism spectrum disorder or developmental, cognitive, sensory, or communication disabilities interact safely with law enforcement by providing training, resources, and materials like blue envelopes containing emergency information. The funding, totaling $5 million annually from 2027 to 2031, prioritizes programs that demonstrate scalability, community support, and input from people with disabilities. The Attorney General must also maintain a public directory of funded programs and submit regular reports to Congress on implementation and best practices.
This bill, known as the Fair Wages for Home Care Workers Act, would change federal labor rules to require overtime pay and minimum wage protections for certain babysitters. It specifically targets casual babysitting work that is irregular or intermittent, while excluding trained medical professionals like nurses and home health aides from these changes. The law would also allow babysitters to perform up to 20% of their work time on unrelated household tasks without losing their protected status. These amendments would apply to workers covered by the Fair Labor Standards Act of 1938 who provide custodial care for infants or children in private homes.
This bill, titled the Safeguarding Women from Chemical Abortion Act, aims to revoke federal approval for the drug mifepristone (also known as RU-486) for use in terminating pregnancies. If enacted, the Food and Drug Administration's approval for mifepristone for this indication would be withdrawn within 14 days, making its introduction into interstate commerce for pregnancy termination a violation of federal law. Additionally, the bill establishes a new federal right for individuals to sue manufacturers of mifepristone if they experience bodily injury or harm to mental health attributed to its use for pregnancy termination. This legislation directly affects drug manufacturers, distributors, healthcare providers, and individuals seeking or having used medication abortion.
This bill would remove the federal approval for the drug mifepristone, which is used in combination with other medications to end pregnancies, and would make it illegal to distribute the drug for that purpose. It also creates a new federal lawsuit option allowing individuals to sue drug manufacturers for physical or mental harm they claim resulted from using mifepristone. The law would take effect 14 days after passing, with the new lawsuit provision becoming active 90 days after enactment.
This bill, titled the Failed Bank Executives Clawback Act, would give the Federal Deposit Insurance Corporation and federal regulators the authority to recover compensation from executives and other high-level personnel at banks that have failed. It directly affects directors, officers, controlling stockholders, and other individuals found primarily responsible for a bank's failure at institutions with over $10 billion in assets. The law would require these individuals to return bonuses, stock awards, and other compensation received in the three years before the bank's insolvency or resolution, with recovered funds going into the Deposit Insurance Fund. Additionally, the bill clarifies the Corporation's authority to take over certain financial companies regardless of how the takeover process was initiated.
This resolution (SRES 630) expresses the U.S. Senate's condolences to the families of two Missouri police officers - Deputy Gabriel Ramirez and Deputy Michael Hislope - who died in the line of duty on February 23, 2026, during a shooting in Christian County. It recognizes the daily sacrifices of all law enforcement officers, condemns violence against them, and affirms support for officers nationwide who protect communities. The resolution serves as a symbolic gesture of honor and remembrance, with no new laws or funding attached. It directly affects the families of the fallen officers and aims to publicly acknowledge the broader law enforcement community's service.
HRES 1110 is a non-binding House resolution expressing the U.S. House of Representatives' disapproval of the slaughter of dogs and cats for human consumption and urging Japan to enact a nationwide ban. It references the U.S. 2018 ban on this practice (under the Agriculture Improvement Act) and notes similar bans in South Korea, Taiwan, and cities like Shenzhen and Jakarta. The resolution affirms shared U.S.-Japan values on animal welfare, encourages bilateral cooperation on animal rights, and clarifies it does not interfere with protected cultural or religious practices. As a symbolic diplomatic statement, it has no legal force but aims to influence Japan’s policies on animal welfare.
